Nov. 25, 2024 — A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain ...

BOSTON — The human brain takes decades to develop Alzheimer’s disease. But scientists have created a miniature version that reveals the same story in just six weeks. A new study has validated a ...

One of the key features of Alzheimer's disease is an accumulation of a harmful protein called tau. In a healthy brain, tau primarily helps to support and stabilise brain cells (neurons). This ...

Known as 'Alzheimer's in a dish,' the model uses cultures of mature brain cells suspended in a gel to recapitulate what takes place in the human brain over 10 to 13 ... Machine Learning Reveals ...

The U.K.'s leading hearing loss organizations have joined forces to highlight misleading reports by some health professionals and the media that hearing loss causes dementia, and treating hearing ...

The main difference between Alzheimer’s and dementia is that Alzheimer’s is a disease in the brain, whereas dementia is a collection of symptoms. Alzheimer’s disease causes cognitive decline, ...

Vascular dementia is the second most common type of dementia (after Alzheimer's disease). Everyone experiences it differently. Symptoms vary depending on the person, the cause and the areas of the ...

The key-pounding pays off. The work Butte's Susan Walsh does with the Butte Montana Threshold Singers and her other choirs is ...

Dementia caused by traumatic brain injury is often static, whereas dementia caused by neurodegenerative disorders, such as Alzheimer's disease, is usually progressive and can eventually be fatal.

Alzheimer's disease is a progressive neurodegenerative disease that impairs memory and cognitive judgment and is often accompanied by mood swings, disorientation and eventually delirium.

A new blood-brain barrier-crossing platform enables the delivery of therapeutic molecules to the brain, offering potential treatments for ALS and Alzheimer’s disease. A study from the Icahn School of ...